Protein A Resins Market Emerging Trend Analysis by EMD Millipore, Danaher Corporation, GE Healthcare, Expedeon, Bio-Rad Laboratories, Sigma-Aldrich Corporation

Protein A Resins market report provides 2024 forecasts built using statistical analysis while covering data from primary research as well as secondary sources that help gain market insights and provide industry growth expectations.

Protein A Resins market will reach USD 900 million by 2024, Antibody purification application segment dominated the industry in 2017 and is likely to retain the position over forthcoming years. Protein A resin is preferred technique of large scale production of monoclonal antibodies. Increasing number of commercial monoclonal antibodies coupled with large scale production to cater to its increasing demand will stimulate the segment growth.

Report Mainly focuses on the top Manufacturers in global market are given bellow

Agarose Bead Technologies (ABT), EMD Millipore, Danaher Corporation, GE Healthcare, Expedeon, Bio-Rad Laboratories, Sigma-Aldrich Corporation, Novasep, GenScript Corporation, Takara Bio, Repligen, Thermo Fisher Scientific, and Tosoh Bioscience

Request a Sample of this premium Research Report@ https://www.marketstudyreport.com/request-a-sample/467904/       

By Application
• Immunoprecipitation
• Antibody Purification

By Product
• Natural Protein A
• Recombinant Protein A

By Matrix Type
• agarose-based matrix
• glass or silica gel-based matrix
• organic polymer-based matrix

By End Use
• Biopharmaceutical Companies
• Clinical Research Laboratories
• Academic Research Institutes
• Contract Research Organizations

Increasing drug discovery and research will substantially influence protein A resin industry growth in the foreseeable future. Developed countries in North America and Europe region spends considerably more compared to developing countries on drug discovery and development. However, developing nations recently taking initiative to boost the drug related research activities. Research and development requires protein A resin for the separation and purification purpose.

However, high cost of protein A resins hampers its affordability rendering significant negative impact on industry growth

Recombinant protein A products are widely used due to associated benefits such as improved solubility and less sensitivity to alkaline conditions. These procedural benefits have enabled recombinant protein A resins to capture dominant position in the industry.

Agarose based matrix is most widely used in the industry compared to other matrix types available. As a result, it holds largest revenue share in 2017. The suitable pH range, greater firmness and superior mechanical strength are some of the benefits associated with agarose-based matrix type.

Clinical research laboratories is forecasted to be a fastest growing segment owing to robust research and development activities and large number of clinical trials carried on monoclonal antibodies.

However, biopharmaceutical firms use protein A resins in large quantities for the purification of monoclonal antibodies. This has enabled them to retain dominant position amongst other end users.

UK protein A resins market is forecasted to witness healthy growth in Europe region due to rising investments and increasing government support for the development of novel therapy drugs. Increasing approval of monoclonal antibodies coupled with its increasing demand will further support the industry growth. 

Request a Discount on standard prices of this premium Protein A Resins Market Research Report@ https://www.marketstudyreport.com/check-for-discount/467904/

The above information is provided on a regional and country basis for the following:

The above information is provided on a regional and country basis for the following:
• North America (U.S., Canada)
• Europe (Germany, UK, France, Spain, Italy)
• Asia Pacific (Japan, China, India, South Korea, Australia)
• Latin America (Brazil, Mexico)
• MEA (South Africa, Saudi Arabia, UAE)

Stupendous rise in demand of therapeutic antibodies coupled with rise in the use of chromatography technique will drive the industry growth over forecast timeframe. The demand of monoclonal antibodies is rising across the globe for better management of chronic diseases. Moreover, several monoclonal antibodies are still in late phase of clinical development and are expected to get approval in near future. This will rise the demand for protein A resins for antibody purification on large scale.

To View Full Report@ https://www.marketstudyreport.com/reports/protein-a-resins-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.